Identify novel RNA-based biomarkers for disease diagnostics and patient stratification.
Evaluate gene expression changes in response to drug candidates, aiding in mechanism-of-action studies and toxicity assessments.
Uncover cancer-specific transcriptomic signatures and characterize tumor heterogeneity.
Gain insights into gene regulation in neurodegenerative diseases and immune responses.
Monitor therapeutic gene expression and assess cellular reprogramming outcomes.